AREV Life Sciences Global Corp
OTC: AREVF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Michael C. Withrow
- Employees
- 19,534
- Headquarters
- Coquitlam, Canada
- IPO year
- 2019
- Market cap
- $15.9K
- Website
- https://www.arevlifesciences.com
Loading AREVF…
Loading profile data…Frequently asked questions about AREVF
What does AREV Life Sciences Global Corp (AREVF) do?
AREV Life Sciences Global Corp. operates as an early-stage life science discovery company in Canada. It is involved in the extraction of compounds for consumption and topical use; clinical nutrition business; and Medicine Merchant, a technology platform. The company's pipeline products include SUS-TAINN, a superior utility supplementation therap...
Where does AREVF trade?
AREV Life Sciences Global Corp (AREVF) trades on the Other OTC.
What sector is AREVF in?
AREV Life Sciences Global Corp (AREVF) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of AREV Life Sciences Global Corp?
Michael C. Withrow is the chief executive officer of AREV Life Sciences Global Corp (AREVF).
Where is AREV Life Sciences Global Corp headquartered?
AREV Life Sciences Global Corp is headquartered in Canada.
Does AREVF pay a dividend?
AREV Life Sciences Global Corp (AREVF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AREVF go public?
AREV Life Sciences Global Corp (AREVF) completed its initial public offering in 2019.